4//SEC Filing
Dreyer Scott 4
Accession 0001746251-25-000004
CIK 0001267565other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:32 PM ET
Size
11.0 KB
Accession
0001746251-25-000004
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$15.90/sh+17,600$279,840→ 121,213 total - Sale
Common Stock
2025-12-08$47.89/sh−11,125$532,771→ 110,088 total - Sale
Common Stock
2025-12-08$48.66/sh−6,475$315,085→ 103,613 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-12-08−17,600→ 0 totalExercise: $15.90Exp: 2029-01-25→ Common Stock (17,600 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.212 to $48.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.215 to $49.08, inclusive.
- [F4]The option is fully vested and exercisable.
Documents
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001746251
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:32 PM ET
- Size
- 11.0 KB